Merck
@Merck
Today, we announced Phase 2b/3 topline results for our investigational therapy in patients with #DiabeticMacularEdema (DME). This important milestone reflects our ongoing commitment to advancing research in #ophthalmology.
Learn more: go.merck.com/~k7a
Learn more: go.merck.com/~k7a
4 19